Scientists just achieved something genuinely historic — AI-designed viruses that kill antibiotic-resistant bacteria, including tough E. coli strains, with zero risk to humans. This is a real breakthrough in phage therapy that could save countless lives lost to infections modern medicine can no longer treat. Dismissing this milestone as dangerous misses the enormous medical potential on the table.

While Evo cannot design viruses capable of infecting humans, its success highlights both the promise and the risks of AI-driven biotechnology. The technology could accelerate the development of phage therapies for antibiotic-resistant infections, yet it also underscores why robust biosafety safeguards are essential. As AI capabilities improve, preventing the misuse of similar tools to create dangerous pathogens must remain a global priority.